Top Medical News from Across Medscape

  • Shake, Rattle, and Roll: Strategy Improves BP ControlThe Kaiser Permanente intervention asks participants to 'shake' the salt habit; 'rattle' the intensity of blood pressure management, and use interventions easily "rolled" out in the community.
  • Duchenne Muscular Dystrophy Drug Sold Amid ControversyFacing criticism over its $89,000-per-year price tag for a drug now available for $1000 per year, and use of 20-year-old data for FDA approval, Marathon has announced sale of deflazacort to PTC Therapeutics.

Special Report

  • The whirlwind pace of proposed changes to the US healthcare system makes it almost impossible for one person to keep up.  Let us do it for you.

Business of Medicine

  • The State Shouldn't Tell Doctors What to Say, Says Ethicist   Dr Art Caplan, bioethicist, discusses physicians' right to talk to their patients about certain topics, including gun safety and the abortion reversal pill, in view of various state legislation.
  • Saying You're Sorry Might Not Cut It Fess up or clam up? A study weighs in; internist leads liability reform effort; physician carries taint of mega award.

Medscape Editor-in-Chief

  • Eric J. Topol, MD Director, Scripps Translational Science Institute; Chief Academic Officer, Scripps Health; Professor of Genomics, The Scripps Research Institute, La Jolla, California